Literature DB >> 28251252

Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.

Amal El-Sisi1, R Sobhy2, V Jaccoub3, H Hamza2.   

Abstract

Transcatheter closure of perimembranous ventricular septal defects (pmVSDs) is a well-established procedure. Recently, Amplatzer duct occluders (ADO) I and II have been reported to close large series of pmVSDs successfully (off-label use). ADOs are economical compared with the standard Amplatzer VSD occluders, a major consideration in developing countries with low-budget programs. We report closure of symptomatic, hemodynamically significant pmVSDs using the ADOI and ADOII devices. Although there are no set criteria for choosing between ADOI and ADOII, the former's price tag includes snare and long sheath. Thus, we aim to predetermine device usage based on transthoracic echocardiography (TTE) findings. Between March 2013 and November 2014, 30 patients had transcatheter closure of pmVSDs using the ADO devices. The median age was 4 years (range 1.1-13 years) and median weight was 15 kg (range 6.5-85 kg). ADOII could not be used in VSDs larger than 6 mm and/or with a large aneurysm. The median VSD size as assessed by echocardiography was 5.5 mm while the mean was 5.5 mm (range 3-12 mm); while by angiography it was 5 mm & the mean was 4.75 mm (range 3-9 mm). The median fluoroscopy time (FT) was 8 min (range 5-38 min). We inserted ADOI in 13 patients and ADOII in 17 patients (no significant difference between median age and weight in each group). VSD size was significantly larger and FT was longer in ADOI patients; the device type matched what was decided from TTE data in 84% of cases. Follow-up ranged from 2 to 24 months (median 12 months). The mean LVEDD z-score of the patients was 1.1 before VSD closure, while it was 0.63, 0.35, and 0.23 at the 1-, 3 months, and last follow-up, respectively. Complete closure rates immediately, at 24 h, and at last follow-up were 87, 90, and 94% respectively. No patient developed heart block or any other complication. ADOI and ADOII are equally safe and effective in pmVSD closure. ADOII use, although cheaper than ADOI, is limited to smaller VSDs. The choice between ADOI and ADOII can be decided by TTE prior to procedure which is convenient in low economic programs.

Entities:  

Keywords:  ADO1; ADO2; Device closure; Ventricular septal defect

Mesh:

Year:  2017        PMID: 28251252     DOI: 10.1007/s00246-016-1553-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  25 in total

1.  Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block?

Authors:  James R Bentham; Arjun Gujral; Satish Adwani; Nick Archer; Neil Wilson
Journal:  Cardiol Young       Date:  2011-02-01       Impact factor: 1.093

2.  Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial.

Authors:  Jian Yang; Lifang Yang; Shiqiang Yu; Jincheng Liu; Jian Zuo; Wensheng Chen; Weixun Duan; Qijun Zheng; Xuezeng Xu; Jun Li; Jun Zhang; Jian Xu; Lijun Sun; Xiuling Yang; Lize Xiong; Dinghua Yi; Lei Wang; Qingchun Liu; Shuping Ge; Jun Ren
Journal:  J Am Coll Cardiol       Date:  2014-02-05       Impact factor: 24.094

3.  Percutaneous closure of congenital and acquired ventricular septal defects--considerations on selection of the occlusion device.

Authors:  Ina Michel-Behnke; Trong-Phi Le; Bernd Waldecker; Hakan Akintuerk; Klaus Valeske; Dietmar Schranz
Journal:  J Interv Cardiol       Date:  2005-04       Impact factor: 2.279

4.  Residual VSD closure with an ADO II device in an infant.

Authors:  Sivasubramanian Ramakrishnan; Anita Saxena; Shiv Kumar Choudhary
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

5.  Transcatheter occlusion of a residual muscular ventricular septal defect using an Amplatzer duct occluder in a child with congenitally corrected transposition of the great arteries.

Authors:  Gary E Stapleton; Karina M Carlson; Henri Justino
Journal:  Catheter Cardiovasc Interv       Date:  2006-08       Impact factor: 2.692

6.  Percutaneous closure of perimembranous ventricular septal defect with an Amplatzer Duct Occluder in a dextrocardia patient.

Authors:  Oktay Ergene; Cem Nazli; Ugur Kocabas; Hamza Duygu; Zehra Ilke Akyildiz; Ziyad M Hijazi
Journal:  Int J Cardiol       Date:  2009-12-02       Impact factor: 4.164

7.  Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder.

Authors:  Muhammad Dilawar; Mohammed Numan; Amal El-Sisi; Salwa Morcos Gendi; Zaheer Ahmad
Journal:  Pediatr Cardiol       Date:  2007-10-20       Impact factor: 1.655

8.  Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.

Authors:  Ralf Holzer; David Balzer; Qi-Ling Cao; Ken Lock; Ziyad M Hijazi
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

9.  Transcatheter closure of congenital ventricular septal defects: results of the European Registry.

Authors:  Mario Carminati; Gianfranco Butera; Massimo Chessa; Joseph De Giovanni; Gunter Fisher; Marc Gewillig; Mathias Peuster; Jean Francois Piechaud; Giuseppe Santoro; Horst Sievert; Isabella Spadoni; Kevin Walsh
Journal:  Eur Heart J       Date:  2007-08-07       Impact factor: 29.983

Review 10.  Percutaneous closure of ventricular septal defects.

Authors:  Gianfranco Butera; Massimo Chessa; Mario Carminati
Journal:  Cardiol Young       Date:  2007-04-20       Impact factor: 1.093

View more
  11 in total

1.  Percutaneous closure of ventricular septal defects in children: key parameters affecting patient radiation exposure.

Authors:  Raymond N Haddad; Chadia Rizk; Zakhia Saliba; Jad Farah
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

2.  Transthoracic closure of ventricular septal defects guided by transesophageal echocardiography.

Authors:  Huang Jiang-Shan; Sun Kai-Peng; Xu Ning; Zhang Gui-Can; Chen Qiang
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

3.  Current outlook after 4 years since the beginning of interventional cardiology in congenital heart disease in Chiapas State

Authors:  Roberto Mijangos-Vázquez; Rogelio Hernández-Reyes
Journal:  Arch Cardiol Mex       Date:  2022-04-04

4.  Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders.

Authors:  Hieu Lan Nguyen; Quang Tan Phan; Dung Duc Doan; Linh Huynh Dinh; Hieu Ba Tran; Saima Sharmin; Julian Johny Thottian; Hoyoun Won; Wang Soo Lee; Seung Yong Shin; Truong Quang Nguyen; Sang Wook Kim
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

5.  A Comparative Study of Perventricular and Percutaneous Device Closure Treatments for Isolated Ventricular Septal Defect: A Chinese Single-Institution Experience.

Authors:  Xue-Shan Huang; Zeng-Rong Luo; Qiang Chen; Ling-Shan Yu; Hua Cao; Liang-Wan Chen; Gui-Can Zhang
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01

6.  Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: Multicenter Experience.

Authors:  Roberto Mijangos-Vázquez; Amal El-Sisi; Juan P Sandoval Jones; José A García-Montes; Rogelio Hernández-Reyes; Rodina Sobhy; Antoine Abdelmassih; Mohammed M Soliman; Safaa Ali; Tatiana Molina-Sánchez; Carlos Zabal
Journal:  J Interv Cardiol       Date:  2020-02-21       Impact factor: 2.279

7.  Transcatheter Closure of Perimembranous Ventricular Septal Defect with Aneurysm: Radiologic Characteristic and Interventional Strategy.

Authors:  Weibing Guo; Yifan Li; Jinjin Yu; Junjie Li; Ling Sun; Jijun Shi; Shushui Wang; Hong Chen; Zhiwei Zhang
Journal:  J Interv Cardiol       Date:  2020-12-24       Impact factor: 2.279

8.  Percutaneous closure of moderate to large perimembranous ventricular septal defect in small children using left ventricular mid-cavity approach.

Authors:  Sanjiban Ghosh; Aritra Mukherji; Amitabha Chattopadhyay
Journal:  Indian Heart J       Date:  2020-09-06

9.  Percutaneous closure of interventricular septal defect in a pediatric patient with dextrocardia. Clinical case report.

Authors:  Guillermo J Aristizábal-Villa; Alexis E Plata-Marriaga; Mary L Torres-Nieto
Journal:  Arch Cardiol Mex       Date:  2022-04-04

Review 10.  Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects.

Authors:  P Syamasundar Rao; Andrea D Harris
Journal:  F1000Res       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.